Research and Development

UK biotech Antisoma has suffered a disappointing late-stage failure with a potential lung cancer treatment it was developing with Novartis. …

Prime minister Gordon Brown has pledged £250 million for the planned UK Centre for Medical Research and Innovation (UKCMRI). The …

UK law firm Manches has promoted Catherine Rohll to partner in its life sciences team.A scientist by training with a …

Vernalis’ new treatment for neuropathic pain has disappointed in phase II trials and will now be dropped for this indication. …

Trials of a new vaccine which helps fight cancer have been halted after one patient developed encephalitis, a potentially fatal …

PPD is collaborating with the Southern Research Institute in the US to tap into the growing market for contract research …

A round-up of decisions from the Committee for Medicinal Products for Human Use (CHMP), including its recommendation for a chewable version …

Jeffrey Kindler, chairman and chief executive of Pfizer, has been elected chairman of PhRMA, succeeding AstraZeneca’s chief executive David Brennan …

Merck & Co will join in a new US project to create a vaccine research and manufacturing facility designed to …

 

Baxter’s Gammagard has shown promise in treating Alzheimer’s disease, with patients showing better cognitive function and less brain enlargement than …

GlaxoSmithKline has started phase III asthma trials of Relovair, the respiratory treatment it is developing with San Francisco biopharma firm …

Pennsylvania-based Cephalon has signed a deal with the discovery arm of charity Cancer Research UK to develop a new class …

Patients taking part in a clinical trial will sometimes experience a medical emergency, at which point the potential need to …

Novartis’ hypertension treatment Tekturna has failed to show it helps patients recover from a heart attack when added to standard …